Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Recce Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Immuron wins big in US and Europe on travellers’ diarrhoea drug
News
Closing Bell: ASX edges lower as junior mining explorers surge ahead
News
Closing Bell: The ASX lifts with all sectors finishing in the green
Health & Biotech
ASX Health Stocks: Neuren stock price up 100pc on positive Phase 3 results
Health & Biotech
As Biotron more than doubles on promising COVID results, which other ASX stocks are working on treatments?
Health & Biotech
China is about to grant patents like never before, and these ASX stocks have already got some
Health & Biotech
ASX Health Stocks: Noxopharm gets initial nod for patent, Rhythm tops 11pc on imminent market launch
Health & Biotech
ASX health stocks: Proteomics jumps 10% on blood test deal with Nasdaq-listed Abcam
News
Closing Bell: More pain for investors as the ASX 200 falls for second consecutive day
News
Closing Bell: The ASX 200 fell by almost 1pc to start the week
Health & Biotech
ASX health stocks today: AdAlta (ASX:1AD) leads after successful Phase I study
Health & Biotech
ScoPo’s Powerplays: ASX biotech IPOs show ‘money is out there’; Virtus to benefit from rise in IVF
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Recce, Botanix both announce progress on antimicrobial programs
News
Market highlights and 5 ASX small caps to watch on Tuesday
News
Last Orders: ASX finishes firmly in the red led by tech
Health & Biotech